Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Evan Stein

TitleClinical Associate
InstitutionUniversity of Chicago
DepartmentMedicine-Cardiology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Gaudet D, Durst R, Lepor N, Bakker-Arkema R, Bisgaier C, Masson L, Golden L, Kastelein JJ, Hegele RA, Stein E. Usefulness of Gemcabene in Homozygous Familial Hypercholesterolemia (from COBALT-1). Am J Cardiol. 2019 Dec 15; 124(12):1876-1880. PMID: 31685212.
      View in: PubMed
    2. Cho L, Dent R, Stroes ESG, Stein EA, Sullivan D, Ruzza A, Flower A, Somaratne R, Rosenson RS. Persistent Safety and Efficacy of Evolocumab in Patients with Statin Intolerance: a Subset Analysis of the OSLER Open-Label Extension Studies. Cardiovasc Drugs Ther. 2018 08; 32(4):365-372. PMID: 30073585.
      View in: PubMed
    3. Martin SS, Giugliano RP, Murphy SA, Wasserman SM, Stein EA, Ceška R, López-Miranda J, Georgiev B, Lorenzatti AJ, Tikkanen MJ, Sever PS, Keech AC, Pedersen TR, Sabatine MS. Comparison of Low-Density Lipoprotein Cholesterol Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation: Insights From the FOURIER Trial. JAMA Cardiol. 2018 08 01; 3(8):749-753. PMID: 29898218.
      View in: PubMed
    4. Mach F, Ray KK, Wiklund O, Corsini A, Catapano AL, Bruckert E, De Backer G, Hegele RA, Hovingh GK, Jacobson TA, Krauss RM, Laufs U, Leiter LA, März W, Nordestgaard BG, Raal FJ, Roden M, Santos RD, Stein EA, Stroes ES, Thompson PD, Tokgözoglu L, Vladutiu GD, Gencer B, Stock JK, Ginsberg HN, Chapman MJ. Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. Eur Heart J. 2018 07 14; 39(27):2526-2539. PMID: 29718253.
      View in: PubMed
    5. Momtazi AA, Banach M, Pirro M, Stein EA, Sahebkar A. MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia? Clin Rev Allergy Immunol. 2018 Apr; 54(2):224-233. PMID: 28534160.
      View in: PubMed
    6. Kusters DM, Braamskamp MJAM, Langslet G, McCrindle BW, Cassiman D, Francis GA, Gagne C, Gaudet D, Morrison KM, Wiegman A, Turner T, Miller E, Raichlen J, Martin PD, Stein EA, Kastelein JJP, Hutten BA. Response by Kusters et al to Letter Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)". Circulation. 2018 02 06; 137(6):641-642. PMID: 29431667.
      View in: PubMed
    7. Stein EA, Dann EJ, Wiegman A, Skovby F, Gaudet D, Sokal E, Charng MJ, Mohamed M, Luirink I, Raichlen JS, Sundén M, Carlsson SC, Raal FJ, Kastelein JJP. Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations. J Am Coll Cardiol. 2017 Aug 29; 70(9):1162-1170. PMID: 28838366.
      View in: PubMed
    8. Ahuja NK, Agnihotri A, Lynch KL, Hoo-Fatt D, Onyimba F, McKnight M, Okeke FC, Garcia P, Dhalla S, Stein E, Pasricha PJ, Clarke JO. Esophageal distensibility measurement: impact on clinical management and procedure length. Dis Esophagus. 2017 Aug 01; 30(8):1-8. PMID: 28575249.
      View in: PubMed
    9. Stein EA, Turner TA. Are the PCSK9 inhibitors the panacea of atherosclerosis treatment? Expert Rev Cardiovasc Ther. 2017 07; 15(7):491-494. PMID: 28651464.
      View in: PubMed
    10. Braamskamp MJAM, Langslet G, McCrindle BW, Cassiman D, Francis GA, Gagne C, Gaudet D, Morrison KM, Wiegman A, Turner T, Miller E, Kusters DM, Raichlen JS, Martin PD, Stein EA, Kastelein JJP, Hutten BA. Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label). Circulation. 2017 Jul 25; 136(4):359-366. PMID: 28592434.
      View in: PubMed
    11. Ganjali S, Momtazi AA, Banach M, Kovanen PT, Stein EA, Sahebkar A. HDL abnormalities in familial hypercholesterolemia: Focus on biological functions. Prog Lipid Res. 2017 07; 67:16-26. PMID: 28506805.
      View in: PubMed
    12. Dolezelova E, Stein E, Derosa G, Maffioli P, Nachtigal P, Sahebkar A. Effect of ezetimibe on plasma adipokines: a systematic review and meta-analysis. Br J Clin Pharmacol. 2017 07; 83(7):1380-1396. PMID: 28166606.
      View in: PubMed
    13. Raal FJ, Hovingh GK, Blom D, Santos RD, Harada-Shiba M, Bruckert E, Couture P, Soran H, Watts GF, Kurtz C, Honarpour N, Tang L, Kasichayanula S, Wasserman SM, Stein EA. Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study. Lancet Diabetes Endocrinol. 2017 04; 5(4):280-290. PMID: 28215937.
      View in: PubMed
    14. Momtazi AA, Banach M, Pirro M, Stein EA, Sahebkar A. PCSK9 and diabetes: is there a link? Drug Discov Today. 2017 06; 22(6):883-895. PMID: 28111330.
      View in: PubMed
    15. Stein EA. PCSK9: the Critical Role of Familial Hypercholesterolemia from Discovery to Benefit for all : Editorial to: "Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/Dl or Higher" by Henry N. Ginsberg et Al. Cardiovasc Drugs Ther. 2016 10; 30(5):427-431. PMID: 27669716.
      View in: PubMed
    16. Stein E, Bays H, Koren M, Bakker-Arkema R, Bisgaier C. Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients. J Clin Lipidol. 2016 Sep-Oct; 10(5):1212-22. PMID: 27678439.
      View in: PubMed
    17. Raal FJ, Stein EA. The Effects of Mipomersen on Inhibiting Hepatic VLDL Apolipoprotein B100 Synthesis and Propensity for Hepatic Steatosis. Clin Chem. 2016 08; 62(8):1052-3. PMID: 27225832.
      View in: PubMed
    18. Raal FJ, Giugliano RP, Sabatine MS, Koren MJ, Blom D, Seidah NG, Honarpour N, Lira A, Xue A, Chiruvolu P, Jackson S, Di M, Peach M, Somaratne R, Wasserman SM, Scott R, Stein EA. PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role. J Lipid Res. 2016 06; 57(6):1086-96. PMID: 27102113.
      View in: PubMed
    19. Nissen SE, Stroes E, Dent-Acosta RE, Rosenson RS, Lehman SJ, Sattar N, Preiss D, Bruckert E, Ceška R, Lepor N, Ballantyne CM, Gouni-Berthold I, Elliott M, Brennan DM, Wasserman SM, Somaratne R, Scott R, Stein EA. Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial. JAMA. 2016 Apr 19; 315(15):1580-90. PMID: 27039291.
      View in: PubMed
    20. Stein EA. What role will proprotein convertase subtilisin/kexin type 9 inhibitors play in hyperlipidemia management? Curr Opin Endocrinol Diabetes Obes. 2016 Apr; 23(2):97-105. PMID: 26859553.
      View in: PubMed
    21. Nissen SE, Dent-Acosta RE, Rosenson RS, Stroes E, Sattar N, Preiss D, Mancini GB, Ballantyne CM, Catapano A, Gouni-Berthold I, Stein EA, Xue A, Wasserman SM, Scott R, Thompson PD. Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial. Clin Cardiol. 2016 Mar; 39(3):137-44. PMID: 26946077.
      View in: PubMed
    22. Stein EA, Raal F. Future Directions to Establish Lipoprotein(a) as a Treatment for Atherosclerotic Cardiovascular Disease. Cardiovasc Drugs Ther. 2016 Feb; 30(1):101-8. PMID: 26861250.
      View in: PubMed
    23. Walley KR, Francis GA, Opal SM, Stein EA, Russell JA, Boyd JH. The Central Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Septic Pathogen Lipid Transport and Clearance. Am J Respir Crit Care Med. 2015 Dec 01; 192(11):1275-86. PMID: 26252194.
      View in: PubMed
    24. Turner T, Stein EA. Non-statin Treatments for Managing LDL Cholesterol and Their Outcomes. Clin Ther. 2015 Dec 01; 37(12):2751-69. PMID: 26548322.
      View in: PubMed
    25. Stein EA, Raal FJ. Lipid-Lowering Drug Therapy for CVD Prevention: Looking into the Future. Curr Cardiol Rep. 2015 Nov; 17(11):104. PMID: 26385394.
      View in: PubMed
    26. Sabatine MS, Wasserman SM, Stein EA. PCSK9 Inhibitors and Cardiovascular Events. N Engl J Med. 2015 08 20; 373(8):774-5. PMID: 26295078.
      View in: PubMed
    27. Braamskamp MJAM, Langslet G, McCrindle BW, Cassiman D, Francis GA, Gagné C, Gaudet D, Morrison KM, Wiegman A, Turner T, Kusters DM, Miller E, Raichlen JS, Wissmar J, Martin PD, Stein EA, Kastelein JJP. Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study. J Clin Lipidol. 2015 Nov-Dec; 9(6):741-750. PMID: 26687694.
      View in: PubMed
    28. Ladeiras-Lopes R, Agewall S, Tawakol A, Staels B, Stein E, Mentz RJ, Leite-Moreira A, Zannad F, Koenig W. Atherosclerosis: Recent trials, new targets and future directions. Int J Cardiol. 2015 Aug 01; 192:72-81. PMID: 26002254.
      View in: PubMed
    29. Kellogg MD, Ellervik C, Morrow D, Hsing A, Stein E, Sethi AA. Preanalytical considerations in the design of clinical trials and epidemiological studies. Clin Chem. 2015 Jun; 61(6):797-803. PMID: 25901083.
      View in: PubMed
    30. Sabatine MS, Giugliano RP, Wiviott SD, Raal FJ, Blom DJ, Robinson J, Ballantyne CM, Somaratne R, Legg J, Wasserman SM, Scott R, Koren MJ, Stein EA. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015 Apr 16; 372(16):1500-9. PMID: 25773607.
      View in: PubMed
    31. Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, Roden M, Stein E, Tokgözoglu L, Nordestgaard BG, Bruckert E, De Backer G, Krauss RM, Laufs U, Santos RD, Hegele RA, Hovingh GK, Leiter LA, Mach F, März W, Newman CB, Wiklund O, Jacobson TA, Catapano AL, Chapman MJ, Ginsberg HN. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J. 2015 May 01; 36(17):1012-22. PMID: 25694464.
      View in: PubMed
    32. Stein EA, Raal FJ. New therapies for reducing low-density lipoprotein cholesterol. Endocrinol Metab Clin North Am. 2014 Dec; 43(4):1007-33. PMID: 25432394.
      View in: PubMed
    33. Stein EA. Measuring LDL cholesterol: for old and new calculations, is there an optimal formula? Clin Chem. 2014 Dec; 60(12):1466-8. PMID: 25332314.
      View in: PubMed
    34. Raal FJ, Stein EA, Dufour R, Turner T, Civeira F, Burgess L, Langslet G, Scott R, Olsson AG, Sullivan D, Hovingh GK, Cariou B, Gouni-Berthold I, Somaratne R, Bridges I, Scott R, Wasserman SM, Gaudet D. PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial. Lancet. 2015 Jan 24; 385(9965):331-40. PMID: 25282519.
      View in: PubMed
    35. Raal FJ, Honarpour N, Blom DJ, Hovingh GK, Xu F, Scott R, Wasserman SM, Stein EA. Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial. Lancet. 2015 Jan 24; 385(9965):341-50. PMID: 25282520.
      View in: PubMed
    36. Blom DJ, Wasserman SM, Stein EA. Evolocumab in hyperlipidemia. N Engl J Med. 2014 08 28; 371(9):877-8. PMID: 25162896.
      View in: PubMed
    37. Gaudet D, Kereiakes DJ, McKenney JM, Roth EM, Hanotin C, Gipe D, Du Y, Ferrand AC, Ginsberg HN, Stein EA. Effect of alirocumab, a monoclonal proprotein convertase subtilisin/kexin 9 antibody, on lipoprotein(a) concentrations (a pooled analysis of 150 mg every two weeks dosing from phase 2 trials). Am J Cardiol. 2014 Sep 01; 114(5):711-5. PMID: 25060413.
      View in: PubMed
    38. Blom DJ, Hala T, Bolognese M, Lillestol MJ, Toth PD, Burgess L, Ceska R, Roth E, Koren MJ, Ballantyne CM, Monsalvo ML, Tsirtsonis K, Kim JB, Scott R, Wasserman SM, Stein EA. A 52-week placebo-controlled trial of evolocumab in hyperlipidemia. N Engl J Med. 2014 May 08; 370(19):1809-19. PMID: 24678979.
      View in: PubMed
    39. Raal FJ, Stein EA. What matters most in pediatric familial hypercholesterolemia, genotype or phenotype? J Lipid Res. 2014 May; 55(5):793-5. PMID: 24676341.
      View in: PubMed
    40. Stein EA, Giugliano RP, Koren MJ, Raal FJ, Roth EM, Weiss R, Sullivan D, Wasserman SM, Somaratne R, Kim JB, Yang J, Liu T, Albizem M, Scott R, Sabatine MS. Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials. Eur Heart J. 2014 Sep 01; 35(33):2249-59. PMID: 24598985.
      View in: PubMed
    41. Raal FJ, Giugliano RP, Sabatine MS, Koren MJ, Langslet G, Bays H, Blom D, Eriksson M, Dent R, Wasserman SM, Huang F, Xue A, Albizem M, Scott R, Stein EA. Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials. J Am Coll Cardiol. 2014 Apr 08; 63(13):1278-1288. PMID: 24509273.
      View in: PubMed
    42. Stein EA, Raal F. Reduction of low-density lipoprotein cholesterol by monoclonal antibody inhibition of PCSK9. Annu Rev Med. 2014; 65:417-31. PMID: 24422577.
      View in: PubMed
    43. Stein EA. Low-density lipoprotein cholesterol reduction by inhibition of PCSK9. Curr Opin Lipidol. 2013 Dec; 24(6):510-7. PMID: 24184943.
      View in: PubMed
    44. Stein EA, Raal FJ. Targeting LDL: is lower better and is it safe? Best Pract Res Clin Endocrinol Metab. 2014 Jun; 28(3):309-24. PMID: 24840261.
      View in: PubMed
    45. Stein EA, Honarpour N, Wasserman SM, Xu F, Scott R, Raal FJ. Effect of the proprotein convertase subtilisin/kexin 9 monoclonal antibody, AMG 145, in homozygous familial hypercholesterolemia. Circulation. 2013 Nov 05; 128(19):2113-20. PMID: 24014831.
      View in: PubMed
    46. Stein EA, Raal FJ. Insights into PCSK9, low-density lipoprotein receptor, and low-density lipoprotein cholesterol metabolism: of mice and man. Circulation. 2013 Jun 18; 127(24):2372-4. PMID: 23690464.
      View in: PubMed
    47. Elis A, Zhou R, Stein EA. Treatment of familial hypercholesterolaemia in children and adolescents in the last three decades. Cardiol Young. 2014 Jun; 24(3):437-41. PMID: 23659280.
      View in: PubMed
    48. Stein EA, Swergold GD. Potential of proprotein convertase subtilisin/kexin type 9 based therapeutics. Curr Atheroscler Rep. 2013 Mar; 15(3):310. PMID: 23371064.
      View in: PubMed
    49. Stein EA, Raal FJ. Polygenic familial hypercholesterolaemia: does it matter? Lancet. 2013 Apr 13; 381(9874):1255-7. PMID: 23433574.
      View in: PubMed
    50. Sullivan D, Olsson AG, Scott R, Kim JB, Xue A, Gebski V, Wasserman SM, Stein EA. Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial. JAMA. 2012 Dec 19; 308(23):2497-506. PMID: 23128163.
      View in: PubMed
    51. Raal F, Scott R, Somaratne R, Bridges I, Li G, Wasserman SM, Stein EA. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial. Circulation. 2012 Nov 13; 126(20):2408-17. PMID: 23129602.
      View in: PubMed
    52. Roth EM, McKenney JM, Hanotin C, Asset G, Stein EA. Atorvastatin with or without an antibody to PCSK9 in primary hypercholesterolemia. N Engl J Med. 2012 Nov 15; 367(20):1891-900. PMID: 23113833.
      View in: PubMed
    53. Dias CS, Shaywitz AJ, Wasserman SM, Smith BP, Gao B, Stolman DS, Crispino CP, Smirnakis KV, Emery MG, Colbert A, Gibbs JP, Retter MW, Cooke BP, Uy ST, Matson M, Stein EA. Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins. J Am Coll Cardiol. 2012 Nov 06; 60(19):1888-98. PMID: 23083772.
      View in: PubMed
    54. Stein EA, Dufour R, Gagne C, Gaudet D, East C, Donovan JM, Chin W, Tribble DL, McGowan M. Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease. Circulation. 2012 Nov 06; 126(19):2283-92. PMID: 23060426.
      View in: PubMed
    55. Morar A, Stein E. Do age and ethnicity play a role in the perception of facial profile attractiveness? A cross-sectional investigation. SADJ. 2012 Aug; 67(7):390-3. PMID: 23951799.
      View in: PubMed
    56. Ballantyne CM, Bays HE, Kastelein JJ, Stein E, Isaacsohn JL, Braeckman RA, Soni PN. Efficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin-treated patients with persistent high triglycerides (from the ANCHOR study). Am J Cardiol. 2012 Oct 01; 110(7):984-92. PMID: 22819432.
      View in: PubMed
    57. Stein EA, Gipe D, Bergeron J, Gaudet D, Weiss R, Dufour R, Wu R, Pordy R. Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial. Lancet. 2012 Jul 07; 380(9836):29-36. PMID: 22633824.
      View in: PubMed
    58. McKenney JM, Koren MJ, Kereiakes DJ, Hanotin C, Ferrand AC, Stein EA. Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease, SAR236553/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy. J Am Coll Cardiol. 2012 Jun 19; 59(25):2344-53. PMID: 22463922.
      View in: PubMed
    59. Stein EA, Mellis S, Yancopoulos GD, Stahl N, Logan D, Smith WB, Lisbon E, Gutierrez M, Webb C, Wu R, Du Y, Kranz T, Gasparino E, Swergold GD. Effect of a monoclonal antibody to PCSK9 on LDL cholesterol. N Engl J Med. 2012 Mar 22; 366(12):1108-18. PMID: 22435370.
      View in: PubMed
    60. Stein EA. Lipoprotein-associated phospholipase A2 measurements: mass, activity, but little productivity. Clin Chem. 2012 May; 58(5):814-7. PMID: 22419749.
      View in: PubMed
    61. Ballantyne CM, Miller M, Niesor EJ, Burgess T, Kallend D, Stein EA. Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study. Am Heart J. 2012 Mar; 163(3):515-21, 521.e1-3. PMID: 22424025.
      View in: PubMed
    62. Stein EA, Vidt DG, Shepherd J, Cain VA, Anzalone D, Cressman MD. Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: a retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development program. Atherosclerosis. 2012 Apr; 221(2):471-7. PMID: 22304793.
      View in: PubMed
    63. Fayad ZA, Mani V, Woodward M, Kallend D, Abt M, Burgess T, Fuster V, Ballantyne CM, Stein EA, Tardif JC, Rudd JH, Farkouh ME, Tawakol A. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet. 2011 Oct 29; 378(9802):1547-59. PMID: 21908036.
      View in: PubMed
    64. Elis A, Zhou R, Stein EA. Effect of lipid-lowering treatment on natural history of heterozygous familial hypercholesterolemia in past three decades. Am J Cardiol. 2011 Jul 15; 108(2):223-6. PMID: 21545982.
      View in: PubMed
    65. Stein EA, Bays H, O'Brien D, Pedicano J, Piper E, Spezzi A. Lapaquistat acetate: development of a squalene synthase inhibitor for the treatment of hypercholesterolemia. Circulation. 2011 May 10; 123(18):1974-85. PMID: 21518985.
      View in: PubMed
    66. Shu A, Yin MT, Stein E, Cremers S, Dworakowski E, Ives R, Rubin MR. Bone structure and turnover in type 2 diabetes mellitus. Osteoporos Int. 2012 Feb; 23(2):635-41. PMID: 21424265.
      View in: PubMed
    67. Maher L, Phlong P, Mooney-Somers J, Keo S, Stein E, Couture MC, Page K. Amphetamine-type stimulant use and HIV/STI risk behaviour among young female sex workers in Phnom Penh, Cambodia. Int J Drug Policy. 2011 May; 22(3):203-9. PMID: 21316935.
      View in: PubMed
    68. Thongtang N, Ai M, Otokozawa S, Himbergen TV, Asztalos BF, Nakajima K, Stein E, Jones PH, Schaefer EJ. Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation. Am J Cardiol. 2011 Feb 01; 107(3):387-92. PMID: 21257003.
      View in: PubMed
    69. Bays HE, Maki KC, McKenney J, Snipes R, Meadowcroft A, Schroyer R, Doyle RT, Stein E. Long-term up to 24-month efficacy and safety of concomitant prescription omega-3-acid ethyl esters and simvastatin in hypertriglyceridemic patients. Curr Med Res Opin. 2010 Apr; 26(4):907-15. PMID: 20156032.
      View in: PubMed
    70. Akdim F, Visser ME, Tribble DL, Baker BF, Stroes ES, Yu R, Flaim JD, Su J, Stein EA, Kastelein JJ. Effect of mipomersen, an apolipoprotein B synthesis inhibitor, on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia. Am J Cardiol. 2010 May 15; 105(10):1413-9. PMID: 20451687.
      View in: PubMed
    71. Brown WV, Myers GL, Sniderman AD, Stein E. Should we use apoB for risk assessment and as a target for treatment? J Clin Lipidol. 2010 May-Jun; 4(3):144-51. PMID: 21122646.
      View in: PubMed
    72. Avis HJ, Hutten BA, Gagné C, Langslet G, McCrindle BW, Wiegman A, Hsia J, Kastelein JJ, Stein EA. Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia. J Am Coll Cardiol. 2010 Mar 16; 55(11):1121-6. PMID: 20223367.
      View in: PubMed
    73. Bays HE, McKenney J, Maki KC, Doyle RT, Carter RN, Stein E. Effects of prescription omega-3-acid ethyl esters on non--high-density lipoprotein cholesterol when coadministered with escalating doses of atorvastatin. Mayo Clin Proc. 2010 Feb; 85(2):122-8. PMID: 20118387.
      View in: PubMed
    74. Stein EA, Roth EM, Rhyne JM, Burgess T, Kallend D, Robinson JG. Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial. Eur Heart J. 2010 Feb; 31(4):480-8. PMID: 20097702.
      View in: PubMed
    75. Stein EA, Marais AD, Szamosi T, Raal FJ, Schurr D, Urbina EM, Hopkins PN, Karki S, Xu J, Misir S, Melino M. Colesevelam hydrochloride: efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemia. J Pediatr. 2010 Feb; 156(2):231-6.e1-3. PMID: 19879596.
      View in: PubMed
    76. Roth EM, Bays HE, Forker AD, Maki KC, Carter R, Doyle RT, Stein EA. Prescription omega-3 fatty acid as an adjunct to fenofibrate therapy in hypertriglyceridemic subjects. J Cardiovasc Pharmacol. 2009 Sep; 54(3):196-203. PMID: 19597368.
      View in: PubMed
    77. Bays HE, Maki KC, Doyle RT, Stein E. The effect of prescription omega-3 fatty acids on body weight after 8 to 16 weeks of treatment for very high triglyceride levels. Postgrad Med. 2009 Sep; 121(5):145-50. PMID: 19820283.
      View in: PubMed
    78. Stein EA, Stroes ES, Steiner G, Buckley BM, Capponi AM, Burgess T, Niesor EJ, Kallend D, Kastelein JJ. Safety and tolerability of dalcetrapib. Am J Cardiol. 2009 Jul 01; 104(1):82-91. PMID: 19576325.
      View in: PubMed
    79. Stein EA. Low-density lipoprotein cholesterol reduction and prevention of cardiovascular disease. Mayo Clin Proc. 2009 Apr; 84(4):307-9. PMID: 19339646.
      View in: PubMed
    80. Meuwese MC, de Groot E, Duivenvoorden R, Trip MD, Ose L, Maritz FJ, Basart DC, Kastelein JJ, Habib R, Davidson MH, Zwinderman AH, Schwocho LR, Stein EA. ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial. JAMA. 2009 Mar 18; 301(11):1131-9. PMID: 19293413.
      View in: PubMed
    81. Stein EA. Other therapies for reducing low-density lipoprotein cholesterol: medications in development. Endocrinol Metab Clin North Am. 2009 Mar; 38(1):99-119. PMID: 19217514.
      View in: PubMed
    82. Stein EA. Additional lipid lowering trials using surrogate measurements of atherosclerosis by carotid intima-media thickness: more clarity or confusion? J Am Coll Cardiol. 2008 Dec 16; 52(25):2206-9. PMID: 19095140.
      View in: PubMed
    83. van Himbergen TM, Matthan NR, Resteghini NA, Otokozawa S, Ai M, Stein EA, Jones PH, Schaefer EJ. Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers. J Lipid Res. 2009 Apr; 50(4):730-9. PMID: 19043140.
      View in: PubMed
    84. Otokozawa S, Ai M, Van Himbergen T, Asztalos BF, Tanaka A, Stein EA, Jones PH, Schaefer EJ. Effects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levels. Atherosclerosis. 2009 Jul; 205(1):197-201. PMID: 19200542.
      View in: PubMed
    85. Blom DJ, Marais AD, Retterstøl K, Stein EA, Ycas J, Gu Z, Miller E. Rosuvastatin reduces non-high-density lipoprotein cholesterol and lipoprotein remnants in patients with dysbetalipoproteinemia (Fredrickson type III hyperlipoproteinemia). J Clin Lipidol. 2008 Dec; 2(6):418-25. PMID: 21291775.
      View in: PubMed
    86. Stein EA. After ENHANCE: is more LDL cholesterol lowering even better? Clin Chem. 2008 Jun; 54(6):940-2. PMID: 18403568.
      View in: PubMed
    87. Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, Visseren FL, Sijbrands EJ, Trip MD, Stein EA, Gaudet D, Duivenvoorden R, Veltri EP, Marais AD, de Groot E. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008 Apr 03; 358(14):1431-43. PMID: 18376000.
      View in: PubMed
    88. Ai M, Otokozawa S, Asztalos BF, Nakajima K, Stein E, Jones PH, Schaefer EJ. Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels. Am J Cardiol. 2008 Feb 01; 101(3):315-8. PMID: 18237592.
      View in: PubMed
    89. Stein EA, Ballantyne CM, Windler E, Sirnes PA, Sussekov A, Yigit Z, Seper C, Gimpelewicz CR. Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins. Am J Cardiol. 2008 Feb 15; 101(4):490-6. PMID: 18312764.
      View in: PubMed
    90. Marais AD, Raal FJ, Stein EA, Rader DJ, Blasetto J, Palmer M, Wilpshaar W. A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia. Atherosclerosis. 2008 Mar; 197(1):400-6. PMID: 17727860.
      View in: PubMed
    91. Stein EA, Amerena J, Ballantyne CM, Brice E, Farnier M, Guthrie RM, Harats D, Ma PT, Le Maulf F, Melezínková H, Gold A, Sager P. Long-term efficacy and safety of rosuvastatin 40 mg in patients with severe hypercholesterolemia. Am J Cardiol. 2007 Nov 01; 100(9):1387-96. PMID: 17950795.
      View in: PubMed
    92. Stein EA. Statins and children: whom do we treat and when? Circulation. 2007 Aug 07; 116(6):594-5. PMID: 17679628.
      View in: PubMed
    93. Stein EA, Ose L, Retterstøl K, Tonstad S, Schleman M, Harris S, Sager P. Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemia. J Clin Lipidol. 2007 Aug; 1(4):280-6. PMID: 21291692.
      View in: PubMed
    94. Stein EA, Marais AD, Ducobu J, Farnier M, Gavish D, Hauner H, Kaplan AJ, Le Maulf F, Melezínková H. Comparison of short-term renal effects and efficacy of rosuvastatin 40 mg and simvastatin 80 mg, followed by assessment of long-term renal effects of rosuvastatin 40 mg, in patients with dyslipidemia. J Clin Lipidol. 2007 Aug; 1(4):287-99. PMID: 21291693.
      View in: PubMed
    95. Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA, Ballantyne CM, Ginsberg HN. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther. 2007 Jul; 29(7):1354-67. PMID: 17825687.
      View in: PubMed
    96. Avis HJ, Vissers MN, Stein EA, Wijburg FA, Trip MD, Kastelein JJ, Hutten BA. A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2007 Aug; 27(8):1803-10. PMID: 17569881.
      View in: PubMed
    97. van der Steeg WA, Boekholdt SM, Stein EA, El-Harchaoui K, Stroes ES, Sandhu MS, Wareham NJ, Jukema JW, Luben R, Zwinderman AH, Kastelein JJ, Khaw KT. Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk. Ann Intern Med. 2007 May 01; 146(9):640-8. PMID: 17470832.
      View in: PubMed
    98. Leiter LA, Rosenson RS, Stein E, Reckless JP, Schulte KL, Schleman M, Miller P, Palmer M, Sosef F. Efficacy and safety of rosuvastatin 40 mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: results of the POLARIS study. Atherosclerosis. 2007 Oct; 194(2):e154-64. PMID: 17229426.
      View in: PubMed
    99. Asztalos BF, Le Maulf F, Dallal GE, Stein E, Jones PH, Horvath KV, McTaggart F, Schaefer EJ. Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins. Am J Cardiol. 2007 Mar 01; 99(5):681-5. PMID: 17317371.
      View in: PubMed
    100. Stein EA, Corsini A, Gimpelewicz CR, Bortolini M, Gil M. Fluvastatin treatment is not associated with an increased incidence of cancer. Int J Clin Pract. 2006 Sep; 60(9):1028-34. PMID: 16939542.
      View in: PubMed
    101. Stein EA. Are measurements of LDL particles ready for prime time? Clin Chem. 2006 Sep; 52(9):1643-4. PMID: 16940463.
      View in: PubMed
    102. Davidson MH, Bays HE, Stein E, Maki KC, Shalwitz RA, Doyle R. Effects of fenofibrate on atherogenic dyslipidemia in hypertriglyceridemic subjects. Clin Cardiol. 2006 Jun; 29(6):268-73. PMID: 16796078.
      View in: PubMed
    103. Ballantyne CM, Bertolami M, Hernandez Garcia HR, Nul D, Stein EA, Theroux P, Weiss R, Cain VA, Raichlen JS. Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II. Am Heart J. 2006 May; 151(5):975.e1-9. PMID: 16644314.
      View in: PubMed
    104. Barter PJ, Ballantyne CM, Carmena R, Castro Cabezas M, Chapman MJ, Couture P, de Graaf J, Durrington PN, Faergeman O, Frohlich J, Furberg CD, Gagne C, Haffner SM, Humphries SE, Jungner I, Krauss RM, Kwiterovich P, Marcovina S, Packard CJ, Pearson TA, Reddy KS, Rosenson R, Sarrafzadegan N, Sniderman AD, Stalenhoef AF, Stein E, Talmud PJ, Tonkin AM, Walldius G, Williams KM. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med. 2006 Mar; 259(3):247-58. PMID: 16476102.
      View in: PubMed
    105. Stein EA. Are LDL subclass measurements clinically relevant? Nat Clin Pract Endocrinol Metab. 2006 Mar; 2(3):120-1. PMID: 16932267.
      View in: PubMed
    106. Stein EA, Sniderman A, Laskarzewski P. Assessment of reaching goal in patients with combined hyperlipidemia: low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein B. Am J Cardiol. 2005 Nov 07; 96(9A):36K-43K; discussion 34K-35K. PMID: 16291013.
      View in: PubMed
    107. Clauss SB, Holmes KW, Hopkins P, Stein E, Cho M, Tate A, Johnson-Levonas AO, Kwiterovich PO. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia. Pediatrics. 2005 Sep; 116(3):682-8. PMID: 16140708.
      View in: PubMed
    108. Matthews KA, Sowers MF, Derby CA, Stein E, Miracle-McMahill H, Crawford SL, Pasternak RC. Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation (SWAN). Am Heart J. 2005 Jun; 149(6):1066-73. PMID: 15976790.
      View in: PubMed
    109. Davidson MH, Bays H, Rhyne J, Stein E, Rotenberg K, Doyle R. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther. 2005 Jun; 27(6):715-27. PMID: 16117978.
      View in: PubMed
    110. Lamendola C, Abbasi F, Chu JW, Hutchinson H, Cain V, Leary E, McLaughlin T, Stein E, Reaven G. Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia. Am J Cardiol. 2005 Jan 15; 95(2):189-93. PMID: 15642550.
      View in: PubMed
    111. Myers GL, Rifai N, Tracy RP, Roberts WL, Alexander RW, Biasucci LM, Catravas JD, Cole TG, Cooper GR, Khan BV, Kimberly MM, Stein EA, Taubert KA, Warnick GR, Waymack PP. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group. Circulation. 2004 Dec 21; 110(25):e545-9. PMID: 15611379.
      View in: PubMed
    112. Shepherd J, Packard C, Littlejohn TW, Walker J, Stein EA, Smith K, Kallend D, Blasetto JW. Lipid-modifying effects of rosuvastatin in postmenopausal women with hypercholesterolemia who are receiving hormone replacement therapy. Curr Med Res Opin. 2004 Oct; 20(10):1571-8. PMID: 15462690.
      View in: PubMed
    113. Shepherd J, Hunninghake DB, Stein EA, Kastelein JJ, Harris S, Pears J, Hutchinson HG. Safety of rosuvastatin. Am J Cardiol. 2004 Oct 01; 94(7):882-8. PMID: 15464670.
      View in: PubMed
    114. Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial. Clin Ther. 2004 Sep; 26(9):1388-99. PMID: 15531001.
      View in: PubMed
    115. Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Am Heart J. 2004 Sep; 148(3):447-55. PMID: 15389231.
      View in: PubMed
    116. Hunninghake DB, Stein EA, Bays HE, Rader DJ, Chitra RR, Simonson SG, Schneck DW. Rosuvastatin improves the atherogenic and atheroprotective lipid profiles in patients with hypertriglyceridemia. Coron Artery Dis. 2004 Mar; 15(2):115-23. PMID: 15024300.
      View in: PubMed
    117. Stein EA, Strutt K, Southworth H, Diggle PJ, Miller E. Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia. Am J Cardiol. 2003 Dec 01; 92(11):1287-93. PMID: 14636905.
      View in: PubMed
    118. Bays H, Stein EA. Pharmacotherapy for dyslipidaemia--current therapies and future agents. Expert Opin Pharmacother. 2003 Nov; 4(11):1901-38. PMID: 14596646.
      View in: PubMed
    119. Anderson GL, Manson J, Wallace R, Lund B, Hall D, Davis S, Shumaker S, Wang CY, Stein E, Prentice RL. Implementation of the Women's Health Initiative study design. Ann Epidemiol. 2003 Oct; 13(9 Suppl):S5-17. PMID: 14575938.
      View in: PubMed
    120. Sowers M, Crawford SL, Cauley JA, Stein E. Association of lipoprotein(a), insulin resistance, and reproductive hormones in a multiethnic cohort of pre- and perimenopausal women (The SWAN Study). Am J Cardiol. 2003 Sep 01; 92(5):533-7. PMID: 12943872.
      View in: PubMed
    121. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003 Aug 07; 349(6):523-34. PMID: 12904517.
      View in: PubMed
    122. Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, Blasetto JW. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am J Cardiol. 2003 Jul 15; 92(2):152-60. PMID: 12860216.
      View in: PubMed
    123. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE, Aragaki A, Safford M, Stein E, Laowattana S, Mysiw WJ. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA. 2003 May 28; 289(20):2673-84. PMID: 12771114.
      View in: PubMed
    124. Stein EA. The power of statins: aggressive lipid lowering. Clin Cardiol. 2003 Apr; 26(4 Suppl 3):III25-31. PMID: 12708636.
      View in: PubMed
    125. Stein EA. New evidence supporting aggressive lipid lowering. Postgrad Med. 2003 Apr; 113(4 Suppl):31-40. PMID: 19667621.
      View in: PubMed
    126. Ballantyne CM, Corsini A, Davidson MH, Holdaas H, Jacobson TA, Leitersdorf E, März W, Reckless JP, Stein EA. Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med. 2003 Mar 10; 163(5):553-64. PMID: 12622602.
      View in: PubMed
    127. Blasetto JW, Stein EA, Brown WV, Chitra R, Raza A. Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups. Am J Cardiol. 2003 Mar 06; 91(5A):3C-10C; discussion 10C. PMID: 12646336.
      View in: PubMed
    128. Stein EA. Introduction: rosuvastatin--an efficacy assessment based on pooled trial data. Am J Cardiol. 2003 Mar 06; 91(5A):1C-2C. PMID: 12646335.
      View in: PubMed
    129. Ballantyne CM, Stein EA, Paoletti R, Southworth H, Blasetto JW. Efficacy of rosuvastatin 10 mg in patients with the metabolic syndrome. Am J Cardiol. 2003 Mar 06; 91(5A):25C-27C; discussion 28C. PMID: 12646342.
      View in: PubMed
    130. Isaacsohn J, Hunninghake D, Schrott H, Dujovne CA, Knopp R, Weiss SR, Bays H, Crouse JR, Davidson MH, Keilson LM, McKenney J, Korenman SG, Dobs AS, Stein E, Krauss RM, Maccubbin D, Cho M, Plotkin DJ, Mitchel YB. Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia. Clin Cardiol. 2003 Jan; 26(1):18-24. PMID: 12539808.
      View in: PubMed
    131. Stein EA. Management of dyslipidemia in the high-risk patient. Am Heart J. 2002 Dec; 144(6 Suppl):S43-50. PMID: 12486415.
      View in: PubMed
    132. Bays HE, Stein EA, Shah AK, Maccubbin DL, Mitchel YB, Mercuri M. Effects of simvastatin on C-reactive protein in mixed hyperlipidemic and hypertriglyceridemic patients. Am J Cardiol. 2002 Nov 01; 90(9):942-6. PMID: 12398959.
      View in: PubMed
    133. Stein EA. Future trends in the treatment of dyslipidemia. Introduction. Postgrad Med. 2002 Oct; 112(4 Suppl):4-5. PMID: 19667593.
      View in: PubMed
    134. Stein EA. Adult treatment panel III and the management of dyslipidemia risk factors. Postgrad Med. 2002 Oct; 112(4 Suppl):12-7. PMID: 19667595.
      View in: PubMed
    135. Sowers M, Jannausch M, Stein E, Jamadar D, Hochberg M, Lachance L. C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthritis Cartilage. 2002 Aug; 10(8):595-601. PMID: 12479380.
      View in: PubMed
    136. Stein EA. Identification and treatment of individuals at high risk of coronary heart disease. Am J Med. 2002 Jun 03; 112 Suppl 8A:3S-9S. PMID: 12049989.
      View in: PubMed
    137. Stein E. The lower the better? Reviewing the evidence for more aggressive cholesterol reduction and goal attainment. Atheroscler Suppl. 2002 Apr; 2(4):19-23; discussion 23-5. PMID: 11976073.
      View in: PubMed
    138. Stein EA. Managing dyslipidemia in the high-risk patient. Am J Cardiol. 2002 Mar 07; 89(5A):50C-57C. PMID: 11900720.
      View in: PubMed
    139. Davidson M, Ma P, Stein EA, Gotto AM, Raza A, Chitra R, Hutchinson H. Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia. Am J Cardiol. 2002 Feb 01; 89(3):268-75. PMID: 11809427.
      View in: PubMed
    140. Stein EA. An investigative look: selective cholesterol absorption inhibitors--embarking on a new standard of care. Am J Manag Care. 2002 Feb; 8(2 Suppl):S36-9; discussion S45-7. PMID: 11855701.
      View in: PubMed
    141. Black DM, Stein EA. Patients with acute coronary syndromes should received statins. Curr Atheroscler Rep. 2002 Jan; 4(1):11-3. PMID: 11772416.
      View in: PubMed
    142. Stein EA, Black DM. Lipoprotein changes with statins. Curr Atheroscler Rep. 2002 Jan; 4(1):14-8. PMID: 11772417.
      View in: PubMed
    143. Clearfield M, Downs JR, Weis S, Whitney EJ, Kruyer W, Shapiro DR, Stein EA, Langendorfer A, Beere PA, Gotto AM. Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women. J Womens Health Gend Based Med. 2001 Dec; 10(10):971-81. PMID: 11788107.
      View in: PubMed
    144. Stein EA. Statins in children. Why and when. Nutr Metab Cardiovasc Dis. 2001 Oct; 11 Suppl 5:24-9. PMID: 12063772.
      View in: PubMed
    145. Isaacsohn J, Insull W, Stein E, Kwiterovich P, Patrick MA, Brazg R, Dujovne CA, Shan M, Shugrue-Crowley E, Ripa S, Tota R. Long-term efficacy and safety of cerivastatin 0.8 mg in patients with primary hypercholesterolemia. Clin Cardiol. 2001 Sep; 24(9 Suppl):IV1-9. PMID: 11594407.
      View in: PubMed
    146. Stein EA, Farnier M, Waldstreicher J, Mercuri M. Effects of statins on biomarkers of bone metabolism: a randomised trial. Nutr Metab Cardiovasc Dis. 2001 Apr; 11(2):84-7. PMID: 11434192.
      View in: PubMed
    147. Stein E. Laboratory surrogates for anti-atherosclerotic drug development. Am J Cardiol. 2001 Feb 16; 87(4A):21A-26A. PMID: 11243601.
      View in: PubMed
    148. Ballantyne CM, Pazzucconi F, Pintó X, Reckless JP, Stein E, McKenney J, Bortolini M, Chiang YT. Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis. Clin Ther. 2001 Feb; 23(2):177-92. PMID: 11293552.
      View in: PubMed
    149. Stein EA. Aggressive treatment of dyslipidemia: a review of supporting evidence. Cleve Clin J Med. 2001 Feb; 68(2):130-1, 135-6, 137-8, 141-2. PMID: 11220455.
      View in: PubMed
    150. Dujovne CA, Bays H, Davidson MH, Knopp R, Hunninghake DB, Stein EA, Goldberg AC, Jones P, Lipka LJ, Cuffie-Jackson C. Reduction of LDL cholesterol in patients with primary hypercholesterolemia by SCH 48461: results of a multicenter dose-ranging study. J Clin Pharmacol. 2001 Jan; 41(1):70-8. PMID: 11144997.
      View in: PubMed
    151. Stein EA. New statins and new doses of older statins. Curr Atheroscler Rep. 2001 Jan; 3(1):14-8. PMID: 11123843.
      View in: PubMed
    152. Ballantyne CM, Herd JA, Stein EA, Ferlic LL, Dunn JK, Gotto AM, Marian AJ. Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy. J Am Coll Cardiol. 2000 Nov 01; 36(5):1572-8. PMID: 11079660.
      View in: PubMed
    153. Davidson MH, Stein EA, Hunninghake DB, Ose L, Dujovne CA, Insull W, Bertolami M, Weiss SR, Kastelein JJ, Scott RS, Campodónico S, Escobar ID, Schrott HG, Bays H, Stepanavage ME, Wu M, Tate AC, Melino MR, Kush D, Mercuri M, Mitchel YB. Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia. Nutr Metab Cardiovasc Dis. 2000 Oct; 10(5):253-62. PMID: 11213534.
      View in: PubMed
    154. Gotto AM, Whitney E, Stein EA, Shapiro DR, Clearfield M, Weis S, Jou JY, Langendörfer A, Beere PA, Watson DJ, Downs JR, de Cani JS. Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Eur Heart J. 2000 Oct; 21(19):1627-33. PMID: 10988016.
      View in: PubMed
    155. Dobs AS, Schrott H, Davidson MH, Bays H, Stein EA, Kush D, Wu M, Mitchel Y, Illingworth RD. Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia. Metabolism. 2000 Sep; 49(9):1234-8. PMID: 11016911.
      View in: PubMed
    156. Stein E, Plotkin D, Bays H, Davidson M, Dujovne C, Korenman S, Stepanavage M, Mercuri M. Effects of simvastatin (40 and 80 mg/day) in patients with mixed hyperlipidemia. Am J Cardiol. 2000 Aug 15; 86(4):406-11. PMID: 10946033.
      View in: PubMed
    157. Clearfield M, Whitney EJ, Weis S, Downs JR, Shapiro DR, Stein EA, Watson DJ, Langendörfer A, Beere PA, Stamler J, Gotto AM. Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): baseline characteristics and comparison with USA population. J Cardiovasc Risk. 2000 Apr; 7(2):125-33. PMID: 10879416.
      View in: PubMed
    158. Shih WJ, Bachorik PS, Haga JA, Myers GL, Stein EA. Estimating the long-term effects of storage at -70 degrees C on cholesterol, triglyceride, and HDL-cholesterol measurements in stored sera. Clin Chem. 2000 Mar; 46(3):351-64. PMID: 10702522.
      View in: PubMed
    159. Gotto AM, Whitney E, Stein EA, Shapiro DR, Clearfield M, Weis S, Jou JY, Langendörfer A, Beere PA, Watson DJ, Downs JR, de Cani JS. Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Circulation. 2000 Feb 08; 101(5):477-84. PMID: 10662743.
      View in: PubMed
    160. Stein EA. Lipid modulation and atherosclerotic events: extending the clinical spectrum with fibrates and statins. Curr Atheroscler Rep. 2000 Jan; 2(1):11-3. PMID: 11122719.
      View in: PubMed
    161. Ose L, Davidson MH, Stein EA, Kastelein JJ, Scott RS, Hunninghake DB, Campodonico S, Insull W, Escobar ID, Schrott HG, Stepanavage ME, Wu M, Tate AC, Melino MR, Mercuri M, Mitchel YB. Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group. Clin Cardiol. 2000 Jan; 23(1):39-46. PMID: 10680028.
      View in: PubMed
    162. Stein E, Savaskan NE, Ninnemann O, Nitsch R, Zhou R, Skutella T. A role for the Eph ligand ephrin-A3 in entorhino-hippocampal axon targeting. J Neurosci. 1999 Oct 15; 19(20):8885-93. PMID: 10516308.
      View in: PubMed
    163. Melander A, Olsson J, Lindberg G, Salzman A, Howard T, Stang P, Lydick E, Emslie-Smith A, Boyle DI, Evans JM, Macdonald TM, Bain J, Sullivan F. 35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999. Diabetologia. 1999 Aug; 42(Suppl 1):A1-A330. PMID: 27770183.
      View in: PubMed
    164. Stein E, Isaacsohn J, Stoltz R, Mazzu A, Liu MC, Lane C, Heller AH. Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia. Am J Cardiol. 1999 May 15; 83(10):1433-6. PMID: 10335757.
      View in: PubMed
    165. Stein EA, Illingworth DR, Kwiterovich PO, Liacouras CA, Siimes MA, Jacobson MS, Brewster TG, Hopkins P, Davidson M, Graham K, Arensman F, Knopp RH, DuJovne C, Williams CL, Isaacsohn JL, Jacobsen CA, Laskarzewski PM, Ames S, Gormley GJ. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA. 1999 Jan 13; 281(2):137-44. PMID: 9917116.
      View in: PubMed
    166. Stein EA. Management of hyperlipidemia: whom and when to treat and new statin options. Atherosclerosis. 1998 Sep; 139 Suppl 1:ix. PMID: 9811151.
      View in: PubMed
    167. Stein E. Cerivastatin in primary hyperlipidemia--a multicenter analysis of efficacy and safety. Atherosclerosis. 1998 Sep; 139 Suppl 1:S15-22. PMID: 9811154.
      View in: PubMed
    168. Stein E. Cerivastatin in primary hyperlipidemia: a multicenter analysis of efficacy and safety. Am J Cardiol. 1998 Aug 27; 82(4B):40J-46J. PMID: 9737645.
      View in: PubMed
    169. Stein EA, Davidson MH, Dobs AS, Schrott H, Dujovne CA, Bays H, Weiss SR, Melino MR, Stepanavage ME, Mitchel YB. Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group. Am J Cardiol. 1998 Aug 01; 82(3):311-6. PMID: 9708659.
      View in: PubMed
    170. Gidding SS, Stone NJ, Bookstein LC, Laskarzewski PM, Stein EA. Month-to-month variability of lipids, lipoproteins, and apolipoproteins and the impact of acute infection in adolescents. J Pediatr. 1998 Aug; 133(2):242-6. PMID: 9709713.
      View in: PubMed
    171. Stein EA. Prevention of heart disease: is LDL reduction the outcome of choice? Absolutely yes. Value Health. 1998 Jul-Aug; 1(2):115-9. PMID: 16674358.
      View in: PubMed
    172. Isaacsohn JL, Moser M, Stein EA, Dudley K, Davey JA, Liskov E, Black HR. Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Arch Intern Med. 1998 Jun 08; 158(11):1189-94. PMID: 9625398.
      View in: PubMed
    173. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998 May 27; 279(20):1615-22. PMID: 9613910.
      View in: PubMed
    174. Stein EA, Lane M, Laskarzewski P. Comparison of statins in hypertriglyceridemia. Am J Cardiol. 1998 Feb 26; 81(4A):66B-69B. PMID: 9526817.
      View in: PubMed
    175. Gordon BR, Kelsey SF, Dau PC, Gotto AM, Graham K, Illingworth DR, Isaacsohn J, Jones PH, Leitman SF, Saal SD, Stein EA, Stern TN, Troendle A, Zwiener RJ. Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group. Am J Cardiol. 1998 Feb 15; 81(4):407-11. PMID: 9485128.
      View in: PubMed
    176. Stein EA. Extending therapy options in treating lipid disorders: a clinical review of cerivastatin, a novel HMG-CoA reductase inhibitor. Drugs. 1998; 56 Suppl 1:25-31; discussion 33. PMID: 9740538.
      View in: PubMed
    177. Raal FJ, Pilcher GJ, Illingworth DR, Pappu AS, Stein EA, Laskarzewski P, Mitchel YB, Melino MR. Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia. Atherosclerosis. 1997 Dec; 135(2):249-56. PMID: 9430375.
      View in: PubMed
    178. Downs JR, Beere PA, Whitney E, Clearfield M, Weis S, Rochen J, Stein EA, Shapiro DR, Langendorfer A, Gotto AM. Design & rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol. 1997 Aug 01; 80(3):287-93. PMID: 9264420.
      View in: PubMed
    179. Byne W, Stein E. Ethical implications of scientific research on the causes of sexual orientation. Health Care Anal. 1997 Jun; 5(2):136-48. PMID: 10167717.
      View in: PubMed
    180. Davidson M, McKenney J, Stein E, Schrott H, Bakker-Arkema R, Fayyad R, Black D. Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I. Am J Cardiol. 1997 Jun 01; 79(11):1475-81. PMID: 9185636.
      View in: PubMed
    181. Stein E, Sidley C. Orthodontic extrusion--a new simplified aesthetic technique. J Dent Assoc S Afr. 1997 May; 52(5):287-93. PMID: 9461948.
      View in: PubMed
    182. Stein E. Motivation and the orthodontic patient. J Dent Assoc S Afr. 1997 Apr; 52(4):217-21. PMID: 9461995.
      View in: PubMed
    183. Davidson MH, Stein EA, Dujovne CA, Hunninghake DB, Weiss SR, Knopp RH, Illingworth DR, Mitchel YB, Melino MR, Zupkis RV, Dobrinska MR, Amin RD, Tobert JA. The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day. Am J Cardiol. 1997 Jan 01; 79(1):38-42. PMID: 9024733.
      View in: PubMed
    184. Sprecher DL, Harris BV, Stein EA, Bellet PS, Keilson LM, Simbartl LA. Higher triglycerides, lower high-density lipoprotein cholesterol, and higher systolic blood pressure in lipoprotein lipase-deficient heterozygotes. A preliminary report. Circulation. 1996 Dec 15; 94(12):3239-45. PMID: 8989135.
      View in: PubMed
    185. Knopp RH, Illingworth DR, Stein EA, Ginsberg HN, Broyles FE, Behounek BD. Effect of Pravastatin in the Treatment of Patients with Type III Hyperlipoproteinemia. Am J Ther. 1996 Nov; 3(11):755-762. PMID: 11862234.
      View in: PubMed
    186. Chamda RA, Stein E. Time-related bond strengths of light-cured and chemically cured bonding systems: an in vitro study. Am J Orthod Dentofacial Orthop. 1996 Oct; 110(4):378-82. PMID: 8876487.
      View in: PubMed
    187. Heinonen TM, Stein E, Weiss SR, McKenney JM, Davidson M, Shurzinske L, Black DM. The lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked study. Clin Ther. 1996 Sep-Oct; 18(5):853-63. PMID: 8930429.
      View in: PubMed
    188. Pimstone SN, Clee SM, Gagné SE, Miao L, Zhang H, Stein EA, Hayden MR. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers. J Lipid Res. 1996 Aug; 37(8):1675-84. PMID: 8864951.
      View in: PubMed
    189. Nebbe B, Stein E. Orthodontic brackets bonded to glazed and deglazed porcelain surfaces. Am J Orthod Dentofacial Orthop. 1996 Apr; 109(4):431-6. PMID: 8638585.
      View in: PubMed
    190. Grossman M, Rader DJ, Muller DW, Kolansky DM, Kozarsky K, Clark BJ, Stein EA, Lupien PJ, Brewer HB, Raper SE, et al. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med. 1995 Nov; 1(11):1148-54. PMID: 7584986.
      View in: PubMed
    191. Stein EA, Myers GL. National Cholesterol Education Program recommendations for triglyceride measurement: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem. 1995 Oct; 41(10):1421-6. PMID: 7586511.
      View in: PubMed
    192. Bagdade JD, Stein E, Ritter MC. Probucol normalizes cholesteryl ester transfer in IDDM. Diabetes Care. 1995 Oct; 18(10):1341-6. PMID: 8721935.
      View in: PubMed
    193. Haffner S, Orchard T, Stein E, Schmidt D, LaBelle P. Effect of simvastatin on Lp(a) concentrations. Clin Cardiol. 1995 May; 18(5):261-7. PMID: 7628131.
      View in: PubMed
    194. Sweany AE, Shapiro DR, Tate AC, Goldberg RB, Stein EA. Effects of simvastatin versus gemfibrozil on lipids and glucose control in patients with non-insulin-dependent diabetes mellitus. NIDDM Study Group. Clin Ther. 1995 Mar-Apr; 17(2):186-203. PMID: 7614520.
      View in: PubMed
    195. Hunninghake DB, Stein EA, Bremner WF, Greenland P, Demke DM, Oliphant TH. Dose--Response Study of Colestipol Tablets in Patients with Moderate Hypercholesterolemia. Am J Ther. 1995 Mar; 2(3):180-189. PMID: 11847550.
      View in: PubMed
    196. Oyelola OO, Ajayi AA, Babalola RO, Stein EA. Plasma lipids, lipoproteins, and apolipoproteins in Nigerian diabetes mellitus, essential hypertension, and hypertensive-diabetic patients. J Natl Med Assoc. 1995 Feb; 87(2):113-8. PMID: 7897682.
      View in: PubMed
    197. Schrott HG, Stein EA, Dujovne CA, Davidson MH, Goris GB, Oliphant TH, Phillips JC, Shawaryn GG. Enhanced low-density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy. Am J Cardiol. 1995 Jan 01; 75(1):34-9. PMID: 7801861.
      View in: PubMed
    198. Gordon BR, Stein E, Jones P, Illingworth DR. Indications for low-density lipoprotein apheresis. Am J Cardiol. 1994 Dec 01; 74(11):1109-12. PMID: 7977068.
      View in: PubMed
    199. Insull W, Black D, Dujovne C, Hosking JD, Hunninghake D, Keilson L, Knopp R, McKenney J, Stein E, Troendle AJ. Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia. Arch Intern Med. 1994 Nov 14; 154(21):2449-55. PMID: 7979841.
      View in: PubMed
    200. Isaacsohn JL, Setaro JF, Nicholas C, Davey JA, Diotalevi LJ, Christianson DS, Liskov E, Stein EA, Black HR. Effects of lovastatin therapy on plasminogen activator inhibitor-1 antigen levels. Am J Cardiol. 1994 Oct 01; 74(7):735-7. PMID: 7942538.
      View in: PubMed
    201. Stein EA. Drug and alternative therapies for hyperlipidemia. Atherosclerosis. 1994 Aug; 108 Suppl:S105-16. PMID: 7802717.
      View in: PubMed
    202. Illingworth DR, Stein EA, Mitchel YB, Dujovne CA, Frost PH, Knopp RH, Tun P, Zupkis RV, Greguski RA. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial. Arch Intern Med. 1994 Jul 25; 154(14):1586-95. PMID: 8031206.
      View in: PubMed
    203. Grossman M, Raper SE, Kozarsky K, Stein EA, Engelhardt JF, Muller D, Lupien PJ, Wilson JM. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet. 1994 Apr; 6(4):335-41. PMID: 8054972.
      View in: PubMed
    204. Bild DE, Williams RR, Brewer HB, Herd JA, Pearson TA, Stein E. Identification and management of heterozygous familial hypercholesterolemia: summary and recommendations from an NHLBI workshop. Am J Cardiol. 1993 Sep 30; 72(10):1D-5D. PMID: 8105671.
      View in: PubMed
    205. Hunninghake DB, Stein EA, Mellies MJ. Effects of one year of treatment with pravastatin, an HMG-CoA reductase inhibitor, on lipoprotein a. J Clin Pharmacol. 1993 Jun; 33(6):574-80. PMID: 8366183.
      View in: PubMed
    206. Hunninghake DB, Stein EA, Dujovne CA, Harris WS, Feldman EB, Miller VT, Tobert JA, Laskarzewski PM, Quiter E, Held J, et al. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N Engl J Med. 1993 Apr 29; 328(17):1213-9. PMID: 8464431.
      View in: PubMed
    207. Cheng H, Rogers JD, Sweany AE, Dobrinska MR, Stein EA, Tate AC, Amin RD, Quan H. Influence of age and gender on the plasma profiles of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitory activity following multiple doses of lovastatin and simvastatin. Pharm Res. 1992 Dec; 9(12):1629-33. PMID: 1488408.
      View in: PubMed
    208. Wetterau JR, Combs KA, Albers HW, Lamkin G, Stein EA, Barnhart RL, Chi EM, Jackson RL, Harmony JA. Effects of probucol on plasma lipids, lipoproteins and parameters of high density lipoprotein metabolism. Horm Metab Res. 1992 Jun; 24(6):289-96. PMID: 1634195.
      View in: PubMed
    209. Sprecher DL, Kobayashi J, Rymaszewski M, Goldberg IJ, Harris BV, Bellet PS, Ameis D, Yunker RL, Black DM, Stein EA, et al. Trp64----nonsense mutation in the lipoprotein lipase gene. J Lipid Res. 1992 Jun; 33(6):859-66. PMID: 1512512.
      View in: PubMed
    210. Eichner JE, Ferrell RE, Kamboh MI, Kuller LH, Becker DJ, Drash AL, Stein EA, Orchard TJ. The impact of the apolipoprotein E polymorphism on the lipoprotein profile in insulin-dependent diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study IX. Metabolism. 1992 Apr; 41(4):347-51. PMID: 1556940.
      View in: PubMed
    211. Sprecher DL, Knauer SL, Black DM, Kaplan LA, Akeson AA, Dusing M, Lattier D, Stein EA, Rymaszewski M, Wiginton DA. Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families. J Clin Invest. 1991 Sep; 88(3):985-94. PMID: 1885783.
      View in: PubMed
    212. Meilahn EN, Kuller LH, Matthews KA, Wing RR, Caggiula AW, Stein EA. Potential for increasing high-density lipoprotein cholesterol, subfractions HDL2-C and HDL3-C, and apoprotein AI among middle-age women. Prev Med. 1991 Jul; 20(4):462-73. PMID: 1908079.
      View in: PubMed
    213. Lohse P, Mann WA, Stein EA, Brewer HB. Apolipoprotein E-4Philadelphia (Glu13----Lys,Arg145----Cys). Homozygosity for two rare point mutations in the apolipoprotein E gene combined with severe type III hyperlipoproteinemia. J Biol Chem. 1991 Jun 05; 266(16):10479-84. PMID: 1674745.
      View in: PubMed
    214. Black DM, Lamkin G, Olivera EH, Laskarzewski PM, Stein EA. Sleep disturbance and HMG CoA reductase inhibitors. JAMA. 1990 Sep 05; 264(9):1105. PMID: 2384934.
      View in: PubMed
    215. Satterfield S, Greco PJ, Goldhaber SZ, Stampfer MJ, Swartz SL, Stein EA, Kaplan L, Hennekens CH. Biochemical markers of compliance in the Physicians' Health Study. Am J Prev Med. 1990 Sep-Oct; 6(5):290-4. PMID: 2268456.
      View in: PubMed
    216. Gormley GJ, Stoner E, Rittmaster RS, Gregg H, Thompson DL, Lasseter KC, Vlasses PH, Stein EA. Effects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteers. J Clin Endocrinol Metab. 1990 Apr; 70(4):1136-41. PMID: 2156887.
      View in: PubMed
    217. Stryker WS, Stampfer MJ, Stein EA, Kaplan L, Louis TA, Sober A, Willett WC. Diet, plasma levels of beta-carotene and alpha-tocopherol, and risk of malignant melanoma. Am J Epidemiol. 1990 Apr; 131(4):597-611. PMID: 2316493.
      View in: PubMed
    218. Stein E, Kreisberg R, Miller V, Mantell G, Washington L, Shapiro DR. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I. Arch Intern Med. 1990 Feb; 150(2):341-5. PMID: 2405804.
      View in: PubMed
    219. Kaplan LA, Lau JM, Stein EA. Carotenoid composition, concentrations, and relationships in various human organs. Clin Physiol Biochem. 1990; 8(1):1-10. PMID: 2323157.
      View in: PubMed
    220. Stein EA. Lipid risk factors and atherosclerosis: what do we measure? Scand J Clin Lab Invest Suppl. 1990; 198:3-8. PMID: 2189208.
      View in: PubMed
    221. Stein EA. Management of hypercholesterolemia. Approach to diet and drug therapy. Am J Med. 1989 Oct 16; 87(4A):20S-27S. PMID: 2679081.
      View in: PubMed
    222. Goodman DS, Bradford RH, Brewer HB, Brunzell JD, Cleeman JI, Greenland P, Hulley SB, Naito HK, Rifkind B, Stein E, et al. AHA Conference Report on Cholesterol. Diagnosis, evaluation, and treatment: current status and issues. Circulation. 1989 Sep; 80(3):735-8. PMID: 2670324.
      View in: PubMed
    223. Stein E, Ellis PP. Hyphema. Postgrad Med. 1989 Sep 01; 86(3):117-8. PMID: 2771832.
      View in: PubMed
    224. Wones RG, Kerman KM, Hissa DC, Meloy N, Stein EA. Comparisons of referral criteria for public screening of blood cholesterol levels. Public Health Rep. 1989 Sep-Oct; 104(5):425-32. PMID: 2508171.
      View in: PubMed
    225. Stein EA, Trachte GJ. Thromboxane mimetics enhance adrenergic neurotransmission in the rabbit-isolated portal vein. J Cardiovasc Pharmacol. 1989 Sep; 14(3):469-74. PMID: 2476628.
      View in: PubMed
    226. Stein EA, Steiner PM. Triglyceride measurement and its relationship to heart disease. Clin Lab Med. 1989 Mar; 9(1):169-85. PMID: 2647372.
      View in: PubMed
    227. Stein EA. Treatment of familial hypercholesterolemia with drugs in children. Arteriosclerosis. 1989 Jan-Feb; 9(1 Suppl):I145-51. PMID: 2912428.
      View in: PubMed
    228. Meilahn EN, Kuller LH, Stein EA, Caggiula AW, Matthews KA. Characteristics associated with apoprotein and lipoprotein lipid levels in middle-aged women. Arteriosclerosis. 1988 Sep-Oct; 8(5):515-20. PMID: 3142451.
      View in: PubMed
    229. Stryker WS, Kaplan LA, Stein EA, Stampfer MJ, Sober A, Willett WC. The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am J Epidemiol. 1988 Feb; 127(2):283-96. PMID: 3257350.
      View in: PubMed
    230. Hunninghake DB, Miller VT, Goldberg I, Schonfeld G, Stein EA, Tobert JA. Lovastatin: follow-up ophthalmologic data. JAMA. 1988 Jan 15; 259(3):354-5. PMID: 3336156.
      View in: PubMed
    231. Stein EA, Lamkin GE, Bewley DZ. Lovastatin alone and in combination for treatment of primary hypercholesterolemia. Prog Clin Biol Res. 1988; 255:281-93. PMID: 3340642.
      View in: PubMed
    232. Stein EA. Drug therapy in children and adolescents with familial hypercholesterolemia. Prog Clin Biol Res. 1988; 255:273-80. PMID: 3340641.
      View in: PubMed
    233. Havel RJ, Hunninghake DB, Illingworth DR, Lees RS, Stein EA, Tobert JA, Bacon SR, Bolognese JA, Frost PH, Lamkin GE, et al. Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study. Ann Intern Med. 1987 Nov; 107(5):609-15. PMID: 3662274.
      View in: PubMed
    234. Donahue RP, Orchard TJ, Stein EA, Kuller LH. Lack of an association between coffee consumption and lipoprotein lipids and apolipoproteins in young adults: the Beaver County Study. Prev Med. 1987 Nov; 16(6):796-802. PMID: 3432229.
      View in: PubMed
    235. Trachte GJ, Stein E, Peach MJ. Alpha adrenergic receptors mediate angiotensin-induced prostaglandin production in the rabbit isolated vas deferens. J Pharmacol Exp Ther. 1987 Feb; 240(2):433-40. PMID: 3027311.
      View in: PubMed
    236. Mellies MJ, Stein EA, Khoury P, Lamkin G, Glueck CJ. Effects of fenofibrate on lipids, lipoproteins, and apolipoproteins in 33 subjects with primary hypercholesterolemia. Atherosclerosis. 1987 Jan; 63(1):57-64. PMID: 3548734.
      View in: PubMed
    237. Kaplan LA, Stein EA, Willett WC, Stampfer MJ, Stryker WS. Reference ranges of retinol, tocopherols, lycopene and alpha- and beta-carotene in plasma by simultaneous high-performance liquid chromatographic analysis. Clin Physiol Biochem. 1987; 5(6):297-304. PMID: 3446430.
      View in: PubMed
    238. Stein EA, DiPersio L, Pesce AJ, Kashyap M, Kao JT, Srivastava L, McNerney C. Enzyme-linked immunoabsorbant assay of apolipoprotein AII in plasma, with use of a monoclonal antibody. Clin Chem. 1986 Jun; 32(6):967-71. PMID: 3085983.
      View in: PubMed
    239. Stein EA, Adolph R, Rice V, Glueck CJ, Spitz HB. Nonprogression of coronary artery atherosclerosis in homozygous familial hypercholesterolemia after 31 months of repetitive plasma exchange. Clin Cardiol. 1986 Mar; 9(3):115-9. PMID: 3948445.
      View in: PubMed
    240. Donahue RP, Orchard TJ, Stein EA, Kuller LH. Apolipoproteins AI, AII and B in young adults: associations with CHD risk factors. The Beaver County experience. J Chronic Dis. 1986; 39(10):823-30. PMID: 3093516.
      View in: PubMed
    241. Stein EA. Rationale for early detection and treatment of hyperlipidemias. Prog Clin Biol Res. 1985; 188:61-6. PMID: 4059259.
      View in: PubMed
    242. Baughman RP, Stein E, MacGee J, Rashkin M, Sahebjami H. Changes in fatty acids in phospholipids of the bronchoalveolar fluid in bacterial pneumonia and in adult respiratory distress syndrome. Clin Chem. 1984 Apr; 30(4):521-3. PMID: 6705194.
      View in: PubMed
    243. Katrangi N, Kaplan LA, Stein EA. Separation and quantitation of serum beta-carotene and other carotenoids by high performance liquid chromatography. J Lipid Res. 1984 Apr; 25(4):400-6. PMID: 6726089.
      View in: PubMed
    244. Starzl TE, Chase HP, Ahrens EH, McNamara DJ, Bilheimer DW, Schaefer EJ, Rey J, Porter KA, Stein E, Francavilla A, Benson LN. Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg. 1983 Sep; 198(3):273-83. PMID: 6615051.
      View in: PubMed
    245. Maxon HR, Chen IW, Gerson M, Sperling M, Stein EA. Diagnostic specificity of serum myoglobin radioimmunoassay for acute myocardial infarction is improved by using age-, sex-, and race-specific reference ranges. Clin Chem. 1982 Oct; 28(10):2179. PMID: 7127753.
      View in: PubMed
    246. Stein EA, Shapero J, McNerney C, Glueck CJ, Tracy T, Gartside P. Changes in plasma lipid and lipoprotein fractions after alteration in dietary cholesterol, polyunsaturated, saturated, and total fat in free-living normal and hypercholesterolemic children. Am J Clin Nutr. 1982 Jun; 35(6):1375-90. PMID: 7081119.
      View in: PubMed
    247. Kaplan LA, Cline D, Gartside P, Burstein S, Sperling M, Stein EA. Hemoglobin A1 in hemolysates from healthy and insulin-dependent diabetic children, as determined with a temperature-controlled minicolumn assay. Clin Chem. 1982 Jan; 28(1):13-8. PMID: 7034998.
      View in: PubMed
    248. Stein EA, Glueck CJ, Wesselman A, Owens ER, Nichols S, Vink P. Repetitive intermittent flow plasma exchange in patients with severe hypercholesterolemia. Atherosclerosis. 1981 Jan-Feb; 38(1-2):149-64. PMID: 7470196.
      View in: PubMed
    249. Chen IW, David R, Maxon HR, Sperling M, Stein EA. Age-, sex-, and race-related differences in myoglobin concentrations in the serum of healthy persons. Clin Chem. 1980 Dec; 26(13):1864-8. PMID: 7438432.
      View in: PubMed
    250. Kaplan LA, Gau N, Stein EA. Collection and storage of serum lactic acid samples at room temperature without deproteinization. Clin Chem. 1980 Jan; 26(1):175-6. PMID: 7356561.
      View in: PubMed
    251. Stein EA, McNeely S, Steiner P. Electrophoretic separation of high-density lipoprotein choelsterol evaluated and compared with the modified lipid research clinic procedure. Clin Chem. 1979 Nov; 25(11):1934-8. PMID: 227620.
      View in: PubMed
    252. Klimov AN, Glueck CJ, Gartside PS, Magracheva EJ, Livtchak MJ, Shestov DB, Anderson DW, Tsang RC, Stein EA, Steiner PM. Cord blood high density lipoproteins: Leningrad and Cincinnati. Pediatr Res. 1979 Mar; 13(3):208-10. PMID: 224370.
      View in: PubMed
    253. Stein EA, Steiner PM, Gartside PS, Glueck CJ. Development and evaluation of a method for quantitation of plasma high-density-lipoprotein cholesterol. Clin Chem. 1978 Jul; 24(7):1112-5. PMID: 207465.
      View in: PubMed
    254. Stein EA. Familial hypo-beta-lipoproteinemia: a family detected by cord blood tests. Am J Dis Child. 1977 Dec; 131(12):1363-5. PMID: 201167.
      View in: PubMed
    255. Stein EA. The lipid disorders centre at the Transvaal Memorial Hospital for Children. A review of the first 30 months. S Afr Med J. 1977 Sep 24; 52(14):573-9. PMID: 198911.
      View in: PubMed
    256. Stein EA, Mendelsohn D, Fleming M, Barnard GD, Carter KJ, du Toit PS, Hansen JD, Bersohn I. Lowering of plasma cholesterol levels in free-living adolescent males; use of natural and synthetic polyunsaturated foods to provide balanced fat diets. Am J Clin Nutr. 1975 Nov; 28(11):1204-16. PMID: 1190100.
      View in: PubMed
    257. Stein EA, Heimann KW. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia. S Afr Med J. 1975 Jul 19; 49(31):1252-6. PMID: 168650.
      View in: PubMed
    258. Stein EA, Pettifor J, Mieny C, Heimann KW, Spitz L, Bersohn I, Saaron I, Dinner M. Portacaval shunt in four patients with homozygous hypercholesterolaemia. Lancet. 1975 Apr 12; 1(7911):832-5. PMID: 48058.
      View in: PubMed
    259. Stein EA, Mieny C, Pettifor J, Dinner M. Portacaval shunt in two patients with homozygous hypercholesterolemia. Adv Exp Med Biol. 1975; 63:405-16. PMID: 173154.
      View in: PubMed
    260. Przybyla AC, Paulay KL, Stein E, Damato AN. Effects of digoxin on atrioventricular conduction patterns in man. Am J Cardiol. 1974 Mar; 33(3):344-50. PMID: 4591111.
      View in: PubMed
    261. Stein EA, Bersohn I, Mendelsohn D. Letter: Type IV hyperlipidaemia in cord blood. Br Med J. 1974 Feb 02; 1(5900):197. PMID: 4359747.
      View in: PubMed
    262. Stein EA, Mendelsohn D, Bersohn I. Familial type II hyperlipoproteinaemia. Clinical features and results of treatment in children and young adults. S Afr Med J. 1974 Jan 26; 48(4):135-8. PMID: 4363092.
      View in: PubMed
    263. Stein E, Jackler I, Stimmel B, Stein W, Siltzbach LE. Asymptomatic electrocardiographic alterations in sarcoidosis. Am Heart J. 1973 Oct; 86(4):474-7. PMID: 4728123.
      View in: PubMed
    264. Steiner C, Lau SH, Stein E, Wit AL, Weiss MB, Damato AN, Haft JI, Weinstock M, Gupta P. Electrophysiologic documentation of trifascicular block as the common cause of complete heart block. Am J Cardiol. 1971 Oct; 28(4):436-41. PMID: 5095930.
      View in: PubMed
    265. Patton RD, Stein E, Rosen KM, Lau SH, Damato AN. Bundle of His electrograms: a new method for analyzing arrhythmias. Am J Cardiol. 1970 Sep; 26(3):324-7. PMID: 5505458.
      View in: PubMed
    266. Lau SH, Cohen SI, Stein E, Haft JI, Rosen KM, Damato AN. P waves and P loops in coronary sinus and left atrial rhythms. Am Heart J. 1970 Feb; 79(2):201-14. PMID: 5410952.
      View in: PubMed
    267. Damato AN, Lau SH, Helfant RH, Stein E, Berkowitz WD, Cohen SI. Study of atrioventricular conduction in man using electrode catheter recordings of His bundle activity. Circulation. 1969 Mar; 39(3):287-96. PMID: 5766799.
      View in: PubMed
    268. Damato AN, Lau SH, Helfant R, Stein E, Patton RD, Scherlag BJ, Berkowitz WD. A study of heart block in man using His bundle recordings. Circulation. 1969 Mar; 39(3):297-305. PMID: 5766800.
      View in: PubMed
    269. Sun MW, Stein E, Gruen FW. A single column method for the determination of urinary delta-aminolevulinic acid. Clin Chem. 1969 Mar; 15(3):183-9. PMID: 5773268.
      View in: PubMed
    270. Helfant RH, Seuffert GW, Patton RD, Stein E, Damato AN. The clinical use of diphenylhydantoin (dilantin) in the treatment and prevention of cardiac arrhythmias. Am Heart J. 1969 Mar; 77(3):315-23. PMID: 4179761.
      View in: PubMed
    271. Young MW, Lau SH, Stein E, Damato AN. Pseudocoarctation of the aorta. Am Heart J. 1969 Feb; 77(2):259-62. PMID: 5762947.
      View in: PubMed
    272. Scherlag BJ, Lau SH, Helfant RH, Berkowitz WD, Stein E, Damato AN. Catheter technique for recording His bundle activity in man. Circulation. 1969 Jan; 39(1):13-8. PMID: 5782803.
      View in: PubMed
    273. Damato AN, Lau SH, Stein E, Haft JI, Kosowsky B, Cohen SI. Cardiovascular response to acute thermal stress (hot dry environment) in unacclimatized normal subjects. Am Heart J. 1968 Dec; 76(6):769-74. PMID: 5721834.
      View in: PubMed
    274. Cohen SI, Lau SH, Stein E, Young MW, Damato AN. Variations of aberrant ventricular conduction in man: evidence of isolated and combined block within the specialized conduction system. An electrocardiographic and vectorcardiographic study. Circulation. 1968 Nov; 38(5):899-916. PMID: 5697688.
      View in: PubMed
    275. Lau SH, Cohen SI, Stein E, Haft JI, Kinney MJ, Young MW, Helfant RH, Damato AN. Controlled heart rate by atrial pacing in angina pectoris. A determinant of electrocardiographic S-T depression. Circulation. 1968 Oct; 38(4):711-20. PMID: 5677956.
      View in: PubMed
    276. Kosowsky BD, Haft JI, Lau SH, Stein E, Damato AN. The effects of digitalis on atrioventricular conduction in man. Am Heart J. 1968 Jun; 75(6):736-42. PMID: 5649438.
      View in: PubMed
    277. Delman AJ, Robinson G, Stein E, Yahr W, Lister JW. Precise determination of cardiac arrhythmias during open heart surgery monitoring of myocardial electrograms. Am J Cardiol. 1968 May; 21(5):714-21. PMID: 5645085.
      View in: PubMed
    278. Kleinfeld M, Stein E. Electrical alternans of compenents of action potential. Am Heart J. 1968 Apr; 75(4):528-30. PMID: 5647466.
      View in: PubMed
    279. Haft JI, Lau SH, Stein E, Kosowsky BD, Damato AN. Atrial fibrillation produced by atrial stimulation. Circulation. 1968 Jan; 37(1):70-4. PMID: 5634731.
      View in: PubMed
    280. Haft JI, Kosowsky BD, Lau SH, Stein E, Damato AN. Termination of atrial flutter by rapid electrical pacing of the atrium. Am J Cardiol. 1967 Aug; 20(2):239-44. PMID: 4951349.
      View in: PubMed
    281. Ptashkin D, Stein E, Warbasse JR. Congenital dextrocardia with anterior wall myocardial infarction. Am Heart J. 1967 Aug; 74(2):263-7. PMID: 4952731.
      View in: PubMed
    282. Lister JW, Damato AN, Kosowsky BD, Lau SH, Stein E. The hemodynamic effect of slowing the heart rate by paired or coupled stimulation of the atria. Am Heart J. 1967 Mar; 73(3):362-8. PMID: 6019197.
      View in: PubMed
    283. Lau SH, Stein E, Kosowsky BD, Haft JI, Lister JW, Damato AN. Atrial pacing and atrioventricular conduction in anomalous atrioventricular excitation (Wolff-Parkinson-White syndrome). Am J Cardiol. 1967 Mar; 19(3):354-9. PMID: 6020305.
      View in: PubMed
    284. Lister JW, Delman AJ, Stein E, Grunwald R, Robinson G. The dominant pacemaker of the human heart. Antegrade and retrograde activation of the heart. Circulation. 1967 Jan; 35(1):22-31. PMID: 6016053.
      View in: PubMed
    285. Kosowsky BD, Stein E, Lau SH, Lister JW, Haft JI, Damato AN. A comparison of the hemodynamic effects of tachycardia produced by atrial pacing and atropine. Am Heart J. 1966 Nov; 72(5):594-9. PMID: 5923042.
      View in: PubMed
    286. Lister JW, Escher DJ, Furman S, Schwedel JB, Stein E, Damato AN. Heart block: a method for rapid determination of causes of pacing failure in artificial pacemaking systems. Am J Cardiol. 1966 Jul; 18(1):64-72. PMID: 5938913.
      View in: PubMed
    287. Stein E, Damato AN, Kosowsky BD, Lau SH, Lister JW. The relation of heart rate to cardiovascular dynamics. Pacing by atrial electrodes. Circulation. 1966 Jun; 33(6):925-32. PMID: 5940519.
      View in: PubMed
    288. Delman AJ, Gordon GM, Stein E, Escher DJ. The second sound-mitral opening snap (A2-OS) interval during exercise in the evaluation of mitral stenosis. Circulation. 1966 Mar; 33(3):399-403. PMID: 5904417.
      View in: PubMed
    289. Lister JW, Stein E, Kosowsky BD, Lau SH, Damato AN. Atrioventricular conduction in man. Effect of rate, exercise, isoproterenol and atropine on the P-R interval. Am J Cardiol. 1965 Oct; 16(4):516-23. PMID: 5834472.
      View in: PubMed
    290. DELMAN AJ, STEIN E. ATRIAL FLUTTER SECONDARY TO DIGITALIS TOXICITY. REPORT OF THREE CASES AND REVIEW OF THE LITERATURE. Circulation. 1964 Apr; 29:SUPPL:593-7. PMID: 14137493.
      View in: PubMed
    291. KLEINFELD M, STEIN E, KOSSMANN CE. Electrical alternans with emphasis on recent observations made by means of single-cell electrical recording. Am Heart J. 1963 Apr; 65:495-500. PMID: 14042191.
      View in: PubMed
    292. SCHETTLER G, LOHR GW, STEIN E. [The role of essential hyperlipemia & hypercholesteremia in the pathogenesis of myocardial infarcts; a contribution to the causal evaluation of cardiacs with infarcts]. Dtsch Med Wochenschr. 1957 Apr 26; 82(17):610-3. PMID: 13437778.
      View in: PubMed
    Stein's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _